Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 399

1.

Mapping the binding sites of antibodies utilized in programmed cell death ligand-1 predictive immunohistochemical assays for use with immuno-oncology therapies.

Lawson NL, Dix CI, Scorer PW, Stubbs CJ, Wong E, Hutchinson L, McCall EJ, Schimpl M, DeVries E, Walker J, Williams GH, Hunt J, Barker C.

Mod Pathol. 2019 Sep 26. doi: 10.1038/s41379-019-0372-z. [Epub ahead of print]

PMID:
31558782
2.

Mutational Profile Using Next-Generation Sequencing May Aid in the Diagnosis and Treatment of Urachal Adenocarcinoma.

Cornejo KM, Cosar EF, Paner GP, Yang P, Tomaszewicz K, Meng X, Mehta V, Sirintrapun SJ, Barkan GA, Hutchinson L.

Int J Surg Pathol. 2019 Sep 8:1066896919872535. doi: 10.1177/1066896919872535. [Epub ahead of print]

PMID:
31496327
3.

Metastatic Signet Ring Cell Carcinoma of the Ampulla of Vater with an Unusually Prolonged Survival.

Javvaji C, Bledsoe JR, Hutchinson L, Cosar EF, McIntosh LJ, Bathini VG.

J Gastrointest Cancer. 2019 Aug 27. doi: 10.1007/s12029-019-00297-8. [Epub ahead of print] No abstract available.

PMID:
31456115
4.

Preliminary Validation for the "BJR method"-A Possible New Mathematical Approach to Methadone Conversion.

Trofimovitch D, Hutchinson L, Baumrucker SJ.

J Pain Palliat Care Pharmacother. 2019 Jul 1:1-7. doi: 10.1080/15360288.2019.1629521. [Epub ahead of print]

PMID:
31260376
5.

Somatic molecular analysis augments cytologic evaluation of pancreatic cyst fluids as a diagnostic tool.

Sakhdari A, Moghaddam PA, Ok CY, Walter O, Tomaszewicz K, Caporelli ML, Meng X, LaFemina J, Whalen G, Belkin E, Zivny J, Wassef W, Woda BA, Hutchinson LM, Cosar EF.

Oncotarget. 2019 Jun 18;10(40):4026-4037. doi: 10.18632/oncotarget.26999. eCollection 2019 Jun 18.

6.

Analyzing and Reanalyzing the Genome: Findings from the MedSeq Project.

Machini K, Ceyhan-Birsoy O, Azzariti DR, Sharma H, Rossetti P, Mahanta L, Hutchinson L, McLaughlin H; MedSeq Project, Green RC, Lebo M, Rehm HL.

Am J Hum Genet. 2019 Jul 3;105(1):177-188. doi: 10.1016/j.ajhg.2019.05.017. Epub 2019 Jun 27.

PMID:
31256874
7.

Prosurvival kinase PIM2 is a therapeutic target for eradication of chronic myeloid leukemia stem cells.

Ma L, Pak ML, Ou J, Yu J, St Louis P, Shan Y, Hutchinson L, Li S, Brehm MA, Zhu LJ, Green MR.

Proc Natl Acad Sci U S A. 2019 May 21;116(21):10482-10487. doi: 10.1073/pnas.1903550116. Epub 2019 May 8.

PMID:
31068472
8.

Dedifferentiated Carcinoma of the Endometrium Associated With Low-Grade Müllerian Adenosarcoma: A Clinicopathologic Case Report Including the Immunohistochemical and Molecular Profile.

Bai S, Hutchinson LM, Meng X, Bai H, Cosar EF, Khan A, Cornejo K.

Int J Gynecol Pathol. 2019 Mar 22. doi: 10.1097/PGP.0000000000000584. [Epub ahead of print]

PMID:
30908285
9.

Death or Damnation: Surrogacy and Religious Beliefs.

Baumrucker SJ, Stolick M, Hutchinson L, Eastridge A, Devereux L, Adkins RW, Carter GT.

Am J Hosp Palliat Care. 2019 Aug;36(8):740-745. doi: 10.1177/1049909118823189. Epub 2019 Jan 16.

PMID:
30650983
10.

The speech-language pathologist's role in supporting the development of self-regulation: A review and tutorial.

Binns AV, Hutchinson LR, Cardy JO.

J Commun Disord. 2019 Mar - Apr;78:1-17. doi: 10.1016/j.jcomdis.2018.12.005. Epub 2018 Dec 21.

PMID:
30605734
11.

Models and Machines: How Deep Learning Will Take Clinical Pharmacology to the Next Level.

Hutchinson L, Steiert B, Soubret A, Wagg J, Phipps A, Peck R, Charoin JE, Ribba B.

CPT Pharmacometrics Syst Pharmacol. 2019 Mar;8(3):131-134. doi: 10.1002/psp4.12377. Epub 2019 Feb 3.

12.

Self-Selected walking speed increases when individuals are aware of being recorded.

Hutchinson LA, Brown MJ, Deluzio KJ, De Asha AR.

Gait Posture. 2019 Feb;68:78-80. doi: 10.1016/j.gaitpost.2018.11.016. Epub 2018 Nov 13.

PMID:
30465945
13.

Heterogeneous mutational profile and prognosis conferred by TP53 mutations in appendiceal mucinous neoplasms.

Zhu X, Salhab M, Tomaszewicz K, Meng X, Mathew C, Bathini V, Switzer B, Walter O, Cosar EF, Wang X, Lambert LA, Hutchinson LM.

Hum Pathol. 2019 Mar;85:260-269. doi: 10.1016/j.humpath.2018.11.011. Epub 2018 Nov 17.

PMID:
30458197
14.

Generation of Endogenous BMP Transcriptional Reporter Cells Through CRISPR/Cas9 Genome Editing.

Hutchinson LD, Bozatzi P, Macartney T, Sapkota GP.

Methods Mol Biol. 2019;1891:29-35. doi: 10.1007/978-1-4939-8904-1_4.

PMID:
30414124
15.

IRS2 mutations linked to invasion in pleomorphic invasive lobular carcinoma.

Zhu S, Ward BM, Yu J, Matthew-Onabanjo AN, Janusis J, Hsieh CC, Tomaszewicz K, Hutchinson L, Zhu LJ, Kandil D, Shaw LM.

JCI Insight. 2018 Apr 19;3(8). pii: 97398. doi: 10.1172/jci.insight.97398. eCollection 2018 Apr 19.

16.

Critically Ill Patient Leaving Against Medical Advice.

Baumrucker SJ, Carter GT, Stolick M, York P, Hutchinson L, Winiger D, Adkins RW.

Am J Hosp Palliat Care. 2018 Nov;35(11):1461-1466. doi: 10.1177/1049909118767664. Epub 2018 Apr 5. No abstract available.

PMID:
29621891
17.

PAWS1 controls Wnt signalling through association with casein kinase 1α.

Bozatzi P, Dingwell KS, Wu KZ, Cooper F, Cummins TD, Hutchinson LD, Vogt J, Wood NT, Macartney TJ, Varghese J, Gourlay R, Campbell DG, Smith JC, Sapkota GP.

EMBO Rep. 2018 Apr;19(4). pii: e44807. doi: 10.15252/embr.201744807. Epub 2018 Mar 7.

18.

Decision-Making on a Deadline: Tracheostomy, Nutrition, and Autonomy.

Baumrucker SJ, Stolick M, Hutchinson L, VandeKieft G, Cullop A, Meade EF, Adkins RW.

Am J Hosp Palliat Care. 2018 Oct;35(10):1355-1361. doi: 10.1177/1049909118760782. Epub 2018 Mar 8. No abstract available.

PMID:
29514482
19.

A descriptive systematic review of salivary therapeutic drug monitoring in neonates and infants.

Hutchinson L, Sinclair M, Reid B, Burnett K, Callan B.

Br J Clin Pharmacol. 2018 Jun;84(6):1089-1108. doi: 10.1111/bcp.13553. Epub 2018 Mar 25.

20.

Next-Generation Sequencing to Detect Deletion of RB1 and ERBB4 Genes in Chromophobe Renal Cell Carcinoma: A Potential Role in Distinguishing Chromophobe Renal Cell Carcinoma from Renal Oncocytoma.

Liu Q, Cornejo KM, Cheng L, Hutchinson L, Wang M, Zhang S, Tomaszewicz K, Cosar EF, Woda BA, Jiang Z.

Am J Pathol. 2018 Apr;188(4):846-852. doi: 10.1016/j.ajpath.2017.12.003. Epub 2018 Jan 31.

PMID:
29353061
21.

Analysis of human resources for oral health globally: inequitable distribution.

Gallagher JE, Hutchinson L.

Int Dent J. 2018 Jun;68(3):183-189. doi: 10.1111/idj.12349. Epub 2018 Jan 3.

PMID:
29297930
22.

Operator Bias Errors Are Reduced Using Standing Marker Alignment Device for Repeated Visit Studies.

Hutchinson L, Schwartz JB, Morton AM, Davis IS, Deluzio KJ, Rainbow MJ.

J Biomech Eng. 2018 Apr 1;140(4). doi: 10.1115/1.4038358.

PMID:
29114765
23.

Autonomy and Withdrawal of Treatment in a Patient With Depression.

Baumrucker SJ, York P, Stolick M, VandeKieft G, Hutchinson L, Adkins RW, Rashid S, Winiger D.

Am J Hosp Palliat Care. 2018 Jun;35(6):908-914. doi: 10.1177/1049909117735308. Epub 2017 Oct 15. No abstract available.

PMID:
29034689
24.

Immunotherapy: Shining light on immune-based mechanisms.

Hutchinson L.

Nat Rev Clin Oncol. 2017 Nov;14(11):648-649. doi: 10.1038/nrclinonc.2017.152. Epub 2017 Sep 19. No abstract available.

PMID:
28925995
25.

Targeted therapies: Survival ENDEAVORs.

Hutchinson L.

Nat Rev Clin Oncol. 2017 Nov;14(11):650. doi: 10.1038/nrclinonc.2017.155. Epub 2017 Sep 19. No abstract available.

PMID:
28925993
26.

Immunotherapy: CRISPR unveils T-cell-resistance mechanisms in tumours.

Hutchinson L.

Nat Rev Clin Oncol. 2017 Nov;14(11):649. doi: 10.1038/nrclinonc.2017.142. Epub 2017 Aug 31. No abstract available.

PMID:
28857079
27.

Targeted therapies: SOLO2 confirms olaparib maintenance in ovarian cancer.

Hutchinson L.

Nat Rev Clin Oncol. 2017 Oct;14(10):586-587. doi: 10.1038/nrclinonc.2017.130. Epub 2017 Aug 16. No abstract available.

PMID:
28812596
28.

Immunotherapy: Adaptive resistance to CARs in glioma.

Hutchinson L.

Nat Rev Clin Oncol. 2017 Oct;14(10):586-587. doi: 10.1038/nrclinonc.2017.126. Epub 2017 Aug 8. No abstract available.

PMID:
28786418
29.

Prevention: Low-fat diet linked to decline in breast cancer mortality.

Hutchinson L.

Nat Rev Clin Oncol. 2017 Sep;14(9):526. doi: 10.1038/nrclinonc.2017.110. Epub 2017 Jul 18. No abstract available.

PMID:
28719583
30.

Targeted therapies: Lenvatinib SELECTs survival benefit.

Hutchinson L.

Nat Rev Endocrinol. 2017 Sep;13(9):500. doi: 10.1038/nrendo.2017.96. Epub 2017 Jul 14. No abstract available.

PMID:
28707680
31.

Targeted therapies: Lenvatinib SELECTs survival benefit.

Hutchinson L.

Nat Rev Clin Oncol. 2017 Aug;14(8):458-459. doi: 10.1038/nrclinonc.2017.103. Epub 2017 Jul 11. No abstract available.

PMID:
28695915
32.

Targeted therapies: Defining the best-in-class in NSCLC.

Hutchinson L.

Nat Rev Clin Oncol. 2017 Aug;14(8):457. doi: 10.1038/nrclinonc.2017.99. Epub 2017 Jun 27. No abstract available.

PMID:
28653679
33.

Immunotherapy: Exploiting PD-1 on TAMs for tumour cell kill.

Hutchinson L.

Nat Rev Clin Oncol. 2017 Jul;14(7):392-393. doi: 10.1038/nrclinonc.2017.87. Epub 2017 Jun 13. No abstract available.

PMID:
28607517
34.

Targeted therapies: J-ALEX hints at new first-line in NSCLC.

Hutchinson L.

Nat Rev Clin Oncol. 2017 Jul;14(7):394. doi: 10.1038/nrclinonc.2017.80. Epub 2017 May 31. No abstract available.

PMID:
28561073
35.

A Comparison of Self-Selected Walking Speeds and Walking Speed Variability When Data Are Collected During Repeated Discrete Trials and During Continuous Walking.

Brown MJ, Hutchinson LA, Rainbow MJ, Deluzio KJ, De Asha AR.

J Appl Biomech. 2017 Oct 1;33(5):384-387. doi: 10.1123/jab.2016-0355. Epub 2017 Sep 19.

PMID:
28530503
36.

New Insights into the Anatomy of the Midface Musculature and its Implications on the Nasolabial Fold.

Snider CC, Amalfi AN, Hutchinson LE, Sommer NZ.

Aesthetic Plast Surg. 2017 Oct;41(5):1083-1090. doi: 10.1007/s00266-017-0889-9. Epub 2017 May 15.

PMID:
28508263
37.

Targeting endogenous proteins for degradation through the affinity-directed protein missile system.

Fulcher LJ, Hutchinson LD, Macartney TJ, Turnbull C, Sapkota GP.

Open Biol. 2017 May;7(5). pii: 170066. doi: 10.1098/rsob.170066.

38.

Immunotherapy: Cul-TIL-vating uveal melanoma regression.

Hutchinson L.

Nat Rev Clin Oncol. 2017 Jun;14(6):328-329. doi: 10.1038/nrclinonc.2017.61. Epub 2017 Apr 25. No abstract available.

PMID:
28440333
39.

CNS cancer: New chemoradiation standard for elderly patients with glioblastoma.

Hutchinson L.

Nat Rev Clin Oncol. 2017 Jun;14(6):330. doi: 10.1038/nrclinonc.2017.54. Epub 2017 Apr 11. No abstract available.

PMID:
28397827
40.

Haematological cancers: Promising epigenetic targets in leukaemia identified.

Hutchinson L.

Nat Rev Clin Oncol. 2017 May;14(5):261. doi: 10.1038/nrclinonc.2017.51. Epub 2017 Apr 4. No abstract available.

PMID:
28374785
41.

Targeted therapies: New standard for relapsed ALL.

Hutchinson L.

Nat Rev Clin Oncol. 2017 May;14(5):264. doi: 10.1038/nrclinonc.2017.42. Epub 2017 Mar 21. No abstract available.

PMID:
28322244
42.

Targeted therapies: Ibrutinib: new option for relapsed MZL.

Hutchinson L.

Nat Rev Clin Oncol. 2017 Mar 20;14(4):200. doi: 10.1038/nrclinonc.2017.26. No abstract available.

PMID:
28316331
43.

Breast cancer: Utidelone: burden relief in pretreated women.

Hutchinson L.

Nat Rev Clin Oncol. 2017 Apr;14(4):199. doi: 10.1038/nrclinonc.2017.29. Epub 2017 Mar 2. No abstract available.

PMID:
28252004
44.

Biomarkers: Aneuploidy and immune evasion - a biomarker of response.

Hutchinson L.

Nat Rev Clin Oncol. 2017 Feb 20;14(3):140. doi: 10.1038/nrclinonc.2017.23. No abstract available.

PMID:
28218256
45.

Routine Analysis of Lipase in Cyst Fluid Is Unnecessary and Does Not Help Discriminate Between Nonneoplastic and Neoplastic Cystic Pancreatic Lesions.

Sakhdari A, Hutchinson L, Vaskas N, Scott M, Cosar EF, Al-Turkmani R.

Pancreas. 2017 Mar;46(3):e25-e27. doi: 10.1097/MPA.0000000000000789. No abstract available.

PMID:
28187114
46.

Targeted therapies: Selumetinib MEKing differences in NF1.

Hutchinson L.

Nat Rev Clin Oncol. 2017 Mar;14(3):140. doi: 10.1038/nrclinonc.2017.6. Epub 2017 Jan 17. No abstract available.

PMID:
28094260
47.

Lung cancer: ET - platinum therapy comes home.

Hutchinson L.

Nat Rev Clin Oncol. 2017 Feb;14(2):72. doi: 10.1038/nrclinonc.2016.216. Epub 2016 Dec 29. No abstract available.

PMID:
28031558
48.

Lung cancer: AURA3 magic reveals new standard.

Hutchinson L.

Nat Rev Clin Oncol. 2017 Feb;14(2):69. doi: 10.1038/nrclinonc.2016.220. Epub 2016 Dec 29. No abstract available.

PMID:
28031555
49.

Next generation metronomic chemotherapy-report from the Fifth Biennial International Metronomic and Anti-angiogenic Therapy Meeting, 6-8 May 2016, Mumbai.

Pantziarka P, Hutchinson L, André N, Benzekry S, Bertolini F, Bhattacharjee A, Chiplunkar S, Duda DG, Gota V, Gupta S, Joshi A, Kannan S, Kerbel R, Kieran M, Palazzo A, Parikh A, Pasquier E, Patil V, Prabhash K, Shaked Y, Sholler GS, Sterba J, Waxman DJ, Banavali S.

Ecancermedicalscience. 2016 Nov 2;10:689. eCollection 2016.

50.

Targeted therapies: Widening the treatment NET.

Hutchinson L.

Nat Rev Clin Oncol. 2017 Jan;14(1):2-3. doi: 10.1038/nrclinonc.2016.198. Epub 2016 Nov 29. No abstract available.

PMID:
27898066

Supplemental Content

Loading ...
Support Center